Chagas Disease: Current Epidemiological Trends after the Interruption of Vectorial and Transfusional Transmission in the Southern Cone Countries

Memorias do Instituto Oswaldo Cruz

Volumn 98, Issue 5, 2003, Pages 577-591

  Moncayo, Alvaro ^a  

^a UNIVERSIDAD DE LOS ANDES   (Colombia)

Author keywords

Chagas disease; Control; Interruption of transmission; Trypanosoma cruzi infection

Indexed keywords

BACTERIAL TRANSMISSION; BLOOD TRANSFUSION; CHAGAS DISEASE; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; GEOGRAPHIC DISTRIBUTION; GEOGRAPHICAL VARIATION (SPECIES); HEALTH PROGRAM; INFECTION CONTROL; INFECTION RATE; NONHUMAN; PARASITE INCIDENCE; PARASITE PREVALENCE; PARASITE VECTOR; REVIEW; SUSTAINABLE DEVELOPMENT; TRYPANOSOMA CRUZI; VECTOR CONTROL; ZOONOSIS; ANIMAL; ARTICLE; DISEASE CARRIER; ECONOMICS; ENDEMIC DISEASE; HUMAN; INCIDENCE; INSECT CONTROL; METHODOLOGY; MEXICO; PREVALENCE; PUBLIC HEALTH; SOUTH AND CENTRAL AMERICA; WORLD HEALTH ORGANIZATION;

BACTERIA (MICROORGANISMS); TRYPANOSOMA; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; ENDEMIC DISEASES; HUMANS; INCIDENCE; INSECT CONTROL; INSECT VECTORS; LATIN AMERICA; MEXICO; NATIONAL HEALTH PROGRAMS; PAN AMERICAN HEALTH ORGANIZATION; PREVALENCE; TRYPANOSOMA CRUZI;

EID: 0142197130     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762003000500001     Document Type: Review

References (75)

1. Acquatella H 1987. Encuesta epidemiológica en sujetos con serología positiva para enfermedad de Chagas. Ciencia y Tecnología de Venezuela 4: 185-200.
2. Akhavan D 1997. Analysis of Cost-effectiveness of the Chagas Disease Control Program, Ministry of Health, National Health Foundation, Brasília.
3. Arribada AC, Apt W, Ugarte JM 1986. A four-year follow up survey of chagasic cardiopathy in Chile. PAHO Bull 20: 245-266.
4. Camargo M, Segura EL, Kagan IG 1986. Three years of collaboration on the standardization of Chagas disease serodiagnosis: an appraisal. PAHO Bull 20: 233-244.
5. Camargo M, Silva GR, Castillo EA, Silveira AC 1984. Inquérito sorológico da prevalência de infecção chagásica no Brasil 1975/80. Rev Inst Med Trop São Paulo 26: 192-204.
6. Carrasco R 1990. Prevalence of Trypanosoma cruzi infection in blood banks of seven departments of Bolivia. Mem Inst Oswaldo Cruz, 85: 69-73.
7. Cedillos RA 1975. Chagas disease in El Salvador. PAHO Bull 9: 135-141.
8. Cerisola A 1972. Muestreo serológico para la enfermedad de Chagas en conscriptos de la clase 1951. Rev Paraguaya Microbiol 7: 90.
9. Chagas C 1909. Nova tripanozomiase humana. Estudos sobre a morfolojía e o ciclo evolutivo de Schizotrypanum cruzi n.gen., n.sp., ajente etiolójico de nova entidade morbida do homen. Mem Inst Oswaldo Cruz 1: 159-218.
10. Cordova E 1980. Enfermedad de Chagas en el Sur del Perú. Bol Peruano Parasitol 2: 46-50.
11. Coura JR, Abreu LL, Pereira JB, Willcox HPF 1985. Morbidade da doença de Chagas. IV. Estudo longitudinal de dez anos em Pains e Iguatama, Minas Gerais, Brasil. Mem Inst Oswaldo Cruz 80: 73-80.
12. Coura JR, Anunziato N, Willcox HPF 1983. Morbidade da doença de Chagas. I. Estudo de casos procendentes de vários estados do Brasil, observados no Rio de Janeiro. Mem Inst Oswaldo Cruz 78: 363-372.
13. Dias JCP, Brener Z 1984. Chagas disease and blood transfusion. Mem Inst Oswaldo Cruz 79(Supl.): 139-147.
14. Franca ME 1986. Chagas disease in Uruguay in the last twenty years. Rev Méd Uruguay 2: 125-131.
15. Grant IH, Gold JW, Wittner M 1989. Transfusion-associated acute Chagas disease acquired in the United States. Ann Intern Med 111: 849-851.
16. Guhl F 1987. Rastreo seroepidemiológico de donantes de sangre chagásicos en una zona endémica (Norte de Santander, Colombia). Rev Latinoam Microbiol 29: 63-66.
17. Kirchhoff L, Gamm AA, Gilliam FC 1987. American trypanosomiasis (Chagas disease) in Central American immigrants. Am J Trop Med Hyg 82: 915.
18. Liendo F, Salinas P, Contreras MC 1985. Enfermedad de Chagas en Chile. Sectores urbanos. XIII. Prevalencia de infección por Trypanosoma cruzi en donantes de sangre del sector sur del área metropolitana de Santiago. Bol Chileno Parasitol 40: 82-84.
19. López L 1985. Encuesta Serológica de Prevalencia de la Enfermedad de Chagas en Paraguay, Ministerio de Salud, SENEPA, Informe de Proyecto, Asunción, Paraguay.
20. Maguire JH, Hoff R, Sherlock I 1987. Cardiac morbidity and mortality due to Chagas disease: prospective electro-cardiograph study of a Brazilian community. Circula-tion 75: 1140-1145.
21. Marinkelle C 1976. Aspects of Chagas disease in Colombia. In American Trypanosomiasis Research, PAHO Scientific Publication 318, Washington DC, p. 340-346.
22. Marzochi MCA 1981. Chagas disease as an urban problem. Cad Saúde Púb 2: 7-12.
23. Matta V 1985. Seroepidemiología de la enfermedad de Chagas en Guatemala. Memorias VII Congreso Centroamericano de Microbiología, San José, Costa Rica, p. 17.
24. Mercosur 1991. Reunión de Ministros de Salud del Mercosur, Brasília, Junio, Resolución 04-3-CS.
25. Ministry of Health, Funasa 1999. Report to the VIII Meeting of the Intergovernmental Commission of the Southern Cone Initiative, Tarija, Bolivia, 16-18 March.
26. Ministerio de Salud Argentina 2002. Informe del Ministerio de Salud, Buenos Aires.
27. Moncayo A 1997. Progress towards elimination of transmission of Chagas disease in Latin America. WHO Statistics Quarterly 50: 195-198.
28. Moncayo A, Luquetti A 1990. Multicentre double blind study for evaluation of Trypanosoma cruzi defined antigens as diagnostic reagents. Mem Inst Oswaldo Cruz 85: 489-495.
29. Mota EA, Guimaraes AC, Santana O 1990. A nine year prospective study of Chagas disease in a defined rural population in Northeast Brazil. Am J Trop Med Hyg 42: 429-440.
30. Nickerson P, Orr P, Schroeder ML 1989. Transfusion-associated Trypanosoma cruzi infection in a non-endemic area. Ann Intern Med 111: 851-853.
31. Oliveira Filho AM 1988. Development of insecticide formulations and determination of dosages and application schedules to fit specific situations. Rev Argent Microbiol 20 (Supl.): 39-48.
32. Oliveira Filho AM 1997. Uso de nuevas herramientas para el control de triatominos en diferentes situaciones entomológicas en el Continente Americano. Rev Soc Bras Med Trop 30: 41-46.
33. OPS/OMS 1997. Informes de las Iniciativas de los Países Andinos, Bogotá, Febrero y Tegucigalpa, Octubre.
34. OPS/OMS 2001. Informe de la IV Reunión de la Comisión Intergubernamental de la Iniciativa de Centro América, Ciudad de Panamá.
35. PAHO 1974. Aspectos clínicos de la enfermedad de Chagas. Bol Of Sanit Panam 76: 141-155.
36. PAHO 1998a. Report of the VI Meeting of the Intergovernmental Commission of the Southern Cone Initiative, Santiago, Chile, March 1997, OPS/HPC/HCT/98.102, Washington DC, p. 33-36.
37. PAHO 1998b. Report of the VII Meeting of the Intergovernmental Commission of the Southern Cone Initiative, Buenos Aires, Argentina, March, OPS/HPC/HCT/98.114, Washington DC.
38. PAHO/WHO 1999. Treatment of the early chronic phase of Chagas disease in children and adults. Report of an Expert Group, Washington DC.
39. Pereira JB, Willcox HP, Coura JR 1985. Morbidade da doença de Chagas. III. Estudo longitudinal de seis anos, em Virgem da Lapa, MG, Brasil. Mem Inst Oswaldo Cruz 80: 163-171.
40. Pereira MG 1984. Characteristics of urban mortality from Chagas' disease in Brazil's Federal District. Bol Of Sanit Panam 96: 213-221.
41. Pérez A, Segura EL 1989. Blood transfusion and transmission of Chagas infection in Argentina. Rev Argent Transfusión 15: 127-132.
42. Peterson DS, Wrightsman RA, Manning JE 1986. Cloning of a major surface-antigen gene of Trypanosoma cruzi and identification of a nonpeptide repeat. Nature 322: 566-568.
43. Pless M, Juranek D, Kosarsky P 1992. The epidemiology of Chagas' disease in a hyper endemic area of Cochabamba, Bolivia: a clinical study including electrocardiography, seroreactivity to Trypanosoma cruzi, xenodiagnosis, and domiciliary triatomine distribution. Am J Trop Med Hyg 47: 539-546.
44. Ponce C 1984. Prevalencia de la Enfermedad de Chagas en Honduras, Ministerio de Salud, Tegucigalpa, Honduras.
45. Ponce C, Ponce E 1987. Infección por Trypanosoma cruzi en donantes de sangre de diferentes hospitales de Honduras, 8th Latin American Congress of Parasitology, Guatemala, November, p. 260.
46. Reyes Lituma V 1984. Estudio de Prevalencia de Enfermedad de Chagas en Ecuador, Ministerio de Salud, Programa de Control de Vectores, Guayaquil, Ecuador.
47. Salvatella R, Calegari L, Casserone S 1989. Seroprevalencia de anticuerpos contra Trypanosoma cruzi en 13 departamentos del Uruguay. Bol Of Sanit Panam 107: 108-117.
48. Schenone H 1985. Enfermedad de Chagas en Chile. Sectores rurales y periurbanos del área de endemo-enzootia. Relaciones entre condiciones de la vivienda, infestación triatomídea domiciliaria e infección por Trypanosoma cruzi del vector, del humano y de mamíferos domésticos. 1982-1985. Bol Chil Parasitol 40: 58-67.
49. Schmunis GA 1991. Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and no endemic countries. Transfusion 31: 547-557.
50. Schmunis GA, Zicker F, Moncayo A 1996. Interruption of Chagas' disease transmission through vector elimination. The Lancet 9035: 1171.
51. Segura EL, Perez A, Yanovsky JF 1985. Decrease in the prevalence of infection by Trypanosoma cruzi (Chagas disease) in young men of Argentina. Bull PAHO 19: 252-264.
52. Sousa O 1985. Encuesta Serológica de Prevalencia de la Enfermedad de Chagas en Panamá, Laboratorio de Biología, Universidad de Panamá, Informe de Proyecto, Ciudad de Panamá.
53. Souza AG, Wanderley DMV, Buralli 1984. Consolidation of the control of Chagas disease vectors in the state of São Paulo. Mem Inst Oswaldo Cruz 79 (Supl.): 125-131.
54. Sucam, Ministerio da Saúde 1987. Alguns aspectos econômicos e de custo-benefício em doença de Chagas no Brasil, Informações Epidemiológicas, Sucam, V. 54.
55. UNDP/WORLD BANK/WHO 1987. Special Programme for Research and Training in Tropical Diseases, Eighth Programme Report, Geneva, p. 92
56. UNDP/WORLD BANK/WHO 1991. Special Programme for Research and Training in Tropical Diseases, Eleventh Programme Report, Geneva, p. 67
57. UNDP/WORLD BANK/WHO 1994. Special Programme for Research and Training in Tropical Diseases, Trypanosoma cruzi genome project, (http://www.dbbm.fiocruz. br/ TcruziDB/index.html)
58. UNDP/WORLD BANK/WHO 1998a. Special Programme for Research and Training in Tropical Diseases. TDR Newsletter 56: 6.
59. UNDP/WORLD BANK/WHO 1998b. Special Programme for Research and Training in Tropical Diseases, Third External Review, Final Report, p. 27 and Reference Document nr 5.
60. Urbina A 1991. Serologic prevalence of infection with T. cruzi in blood donors in Costa Rica, Abstracts VII Congreso Centroamericano de Microbiología y Parasitología nr 18, p. 204.
61. Valencia A 1990. Investigación Epidemiológica Nacional de la Enfermedad de Chagas, Ministerio de Previsión Social y Salud Pública, La Paz, Bolivia, PL-480 Title III.
62. Velasco Castrejón O, Guzmán Bracho C 1986. Importance of Chagas disease in México. Rev Latinoam Microbiol 28: 275-283.
63. WHO 1994. Chagas disease, elimination of transmission in Uruguay. Weekly Epidemiol Rec 6: 38-40.
64. WHO 1995. Chagas disease, interruption of transmission in Chile. Weekly Epidemiol Rec 3: 13-16.
65. WHO 1996. Chagas disease, progress towards elimination of transmission in Argentina. Weekly Epidemiol Rec 2: 12-15.
66. WHO 1997. Chagas disease, interruption of transmission in Brazil. Weekly Epidemiol Rec 2: 1-5.
67. WHO 1998a. Chagas disease, interruption of transmission in Uruguay. Weekly Epidemiol Rec 2: 1-4.
68. WHO 1998b. 51st World Health Assembly, Resolution WHA51.14.
69. WHO 1999a. Chagas disease, interruption of transmission in Chile. Weekly Epidemiol Rec 2: 9-11.
70. WHO 1999b. Chagas disease, progress towards interruption of transmission in Venezuela. Weekly Epidemiol Rec 35: 289-292.
71. WHO 2000a. Chagas disease, certification of interruption of transmission in Chile. Weekly Epidemiol Rec 2: 10-12.
72. WHO 2000b. Chagas disease, interruption of transmission in Brazil. Weekly Epidemiol Rec 19: 153-155.
73. WHO 2002. Report of the Expert Committee on the control of Chagas disease, Technical Report Series 905, Geneva, p. 85.
74. Zeledón R 1976. Epidemiological pattern of Chagas disease in an endemic area of Costa Rica. Am J Trop Med Hyg 24: 214-225.
75. Zerba EN 1988. Development of new insecticides and synergistic formulations of the Chagas disease vector control. Rev Argent Microbiol 20(Supl.): 25-31.